{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T10:09:45Z","timestamp":1781690985385,"version":"3.54.5"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>How nonalcoholic fatty liver disease (NAFLD) is linked to atherosclerosis is still disputed. This study aimed to explore the association between NAFLD and atherosclerosis among adults in Shandong province, China.<\/jats:p>\n            <jats:p>A total of 6849 individuals were enrolled in the final analyses for a community-based study. The relationship between NAFLD and atherosclerosis was evaluated after adjusting for common confounding factors.<\/jats:p>\n            <jats:p>Hypertension, diabetes, and higher serum low-density lipoprotein cholesterol (LDL-c) level were positively correlated with NAFLD. An odds ratio (OR) (95% confidence interval [CI]) of 1.325 (range 1.157\u20131.518) for hypertension, 2.153 (range 1.814\u20132.555) for diabetes, and 1.161 (range 1.071\u20131.259) for LDL-c was noticed. These factors also were positively correlated with atherosclerosis, with an OR (95% CI) of 1.501 (range 1.286\u20131.751) for hypertension, 1.716 (range 1.414\u20132.084) for diabetes, and 1.344 (range 1.231\u20131.466) for LDL-c. The prevalence of metabolic syndrome was higher in the atherosclerosis+NAFLD group (81.8%) when compared with the NAFLD-only (30.3%), atherosclerosis-only (32.2%), and control (20.3%) groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;.01).<\/jats:p>\n            <jats:p>NAFLD and atherosclerosis have common metabolic characteristics, such as hypertension, diabetes, and higher serum LDL-c level. Patients with NAFLD in combination with atherosclerosis were found to have a more severe metabolic burden and greater chances of having hypertension, diabetes, dyslipidemia, and higher metabolic syndrome scores than those in the other groups.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014896","type":"journal-article","created":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T11:46:07Z","timestamp":1552823167000},"page":"e14896","source":"Crossref","is-referenced-by-count":12,"title":["Nonalcoholic fatty liver disease represents a greater metabolic burden in patients with atherosclerosis"],"prefix":"10.1097","volume":"98","author":[{"given":"Jie","family":"Han","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Jinan"},{"name":"Department of Endocrinology and Metabolism, Hiser Medical Center of Qingdao, Qingdao"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongshang","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Shandong University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Jinan"},{"name":"Institute of Endocrinology and Metabolic Diseases, Shandong Academy of Clinical Medicine, Jinan, Shandong, China.."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Jinan"},{"name":"Institute of Endocrinology and Metabolic Diseases, Shandong Academy of Clinical Medicine, Jinan, Shandong, China.."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Jinan"},{"name":"Institute of Endocrinology and Metabolic Diseases, Shandong Academy of Clinical Medicine, Jinan, Shandong, China.."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Jinan"},{"name":"Institute of Endocrinology and Metabolic Diseases, Shandong Academy of Clinical Medicine, Jinan, Shandong, China.."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Jinan"},{"name":"Institute of Endocrinology and Metabolic Diseases, Shandong Academy of Clinical Medicine, Jinan, Shandong, China.."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Jinan"},{"name":"Institute of Endocrinology and Metabolic Diseases, Shandong Academy of Clinical Medicine, Jinan, Shandong, China.."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gao","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology and Metabolic Diseases, Shandong Academy of Clinical Medicine, Jinan, Shandong, China.."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Jinan"},{"name":"Institute of Endocrinology and Metabolic Diseases, Shandong Academy of Clinical Medicine, Jinan, Shandong, China.."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shandong Provincial Hospital affiliated to Shandong University, Jinan"},{"name":"Institute of Endocrinology and Metabolic Diseases, Shandong Academy of Clinical Medicine, Jinan, Shandong, China.."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.plipres.2015.05.002","article-title":"Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research","volume":"59","author":"Willebrords","year":"2015","journal-title":"Prog Lipid Res"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of non-alcoholic fatty liver disease\u2013meta-analytic assessment of prevalence, incidence and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"(suppl 10C)","key":"R5-20230914","doi-asserted-by":"crossref","first-page":"18L","DOI":"10.1016\/S0002-9149(02)02957-0","article-title":"Intima-media thickness: a tool for atherosclerosis imaging and event prediction","volume":"90","author":"O\u2019Leary","year":"2002","journal-title":"Am J Cardiol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/STROKEAHA.112.673129","article-title":"Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis","volume":"44","author":"Sirimarco","year":"2013","journal-title":"Stroke J Cerebral Circ"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jdiacomp.2015.11.018","article-title":"Prevalence of CHD-related metabolic comorbidity of diabetes mellitus in Northern Chinese adults: the REACTION study","volume":"30","author":"Gao","year":"2016","journal-title":"J Diabetes Complications"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000097034","article-title":"Mannheim carotid intima-media thickness consensus (2004\u20132006)\u2014an update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006","volume":"23","author":"Touboul","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"E766","DOI":"10.1210\/jc.2013-1629","article-title":"Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study","volume":"99","author":"Zhang","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/ard.62.11.1071","article-title":"Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus","volume":"62","author":"Doria","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"(suppl 1)","key":"R11-20230914","first-page":"S11","article-title":"Standards of medical care in diabetes\u20132010","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure\u2014the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"(suppl 1)","key":"R13-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.18.S1.1","article-title":"American Association of Clinical Endocrinologists\u2019 guidelines for management of dyslipidemia and prevention of atherosclerosis","volume":"18","author":"Jellinger","year":"2012","journal-title":"Endocrine Pract"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cgh.2008.11.023","article-title":"Noninvasive assessment of hepatic steatosis","volume":"7","author":"Mazhar","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.292.6512.13","article-title":"Ultrasound scanning in the detection of hepatic fibrosis and steatosis","volume":"292","author":"Saverymuttu","year":"1986","journal-title":"Br Med J"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s10620-013-2743-5","article-title":"Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"58","author":"Stepanova","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.3748\/wjg.v20.i37.13306","article-title":"Nonalcoholic fatty liver disease and vascular disease: state-of-the-art","volume":"20","author":"Fargion","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.metabol.2012.08.005","article-title":"In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not","volume":"62","author":"Younossi","year":"2013","journal-title":"Metabolism"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2007.10.024","article-title":"Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation","volume":"134","author":"Baumeister","year":"2008","journal-title":"Gastroenterology"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.22845","article-title":"Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population","volume":"49","author":"Gastaldelli","year":"2009","journal-title":"Hepatology"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fattly liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1210\/jc.2013-4133","article-title":"Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance","volume":"99","author":"Kim","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1210\/jc.2009-0541","article-title":"Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients","volume":"94","author":"Petit","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2012.10.040","article-title":"The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort","volume":"226","author":"Dick","year":"2013","journal-title":"Atherosclerosis"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1161\/ATVBAHA.112.252957","article-title":"Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese","volume":"32","author":"Huang","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.cgh.2016.01.010","article-title":"Association of nonalcoholic fatty liver disease with visceral adiposity but not coronary artery calcification in the elderly","volume":"14","author":"Jacobs","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","article-title":"Fatty liver: a novel component of the metabolic syndrome","volume":"28","author":"Kotronen","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R32-20230914","first-page":"901","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-Jarvinen","year":"2014","journal-title":"Lacent Diabetes Endocrinol"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","article-title":"Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"33","author":"Dowman","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.3390\/nu7115475","article-title":"The subtle balance between Lipolysis and Lipogenesis: a critical point in metabolic homeostasis","volume":"7","author":"Saponaro","year":"2015","journal-title":"Nutrients"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3390\/ijms17040456","article-title":"Additive effect of non-alcoholic fatty liver disease on metabolic syndrome-related endothelial dysfunction in hypertensive patients","volume":"17","author":"Perticone","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.3748\/wjg.v21.i22.6820","article-title":"Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: an update","volume":"21","author":"Athyros","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R38-20230914","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201903150-00090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:52:49Z","timestamp":1694728369000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201903150-00090"}},"subtitle":["A cross-sectional study"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014896","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}